12 patients met the criteria for dyshormonogenesis of whom eight had permanent and four had transient CH, with molecular genetic confirmation in seven comprising TPO (2), Tg (2), DUOX.2 (2) defect and Pendrin heterozygote (1). This evidence concerns the gene SLC26A4 and cyclic hematopoiesis.